443 filings
Page 3 of 23
4
Machelle Sanders
8 Jun 23
Novan / MACHELLE SANDERS ownership change
9:21pm
4
Bierman James L
8 Jun 23
Novan / JAMES L BIERMAN ownership change
9:21pm
4
Keegan Robert J
8 Jun 23
Novan / ROBERT J KEEGAN ownership change
9:21pm
4
Steven D Skolsky
8 Jun 23
Novan / Steven D Skolsky ownership change
9:21pm
8-K
NOVNQ
NVN Liquidation, Inc.
31 May 23
Novan Focuses Strategic Direction and Announces Restructuring
4:13pm
10-Q
2023 Q1
NOVNQ
NVN Liquidation, Inc.
Quarterly report
15 May 23
6:55am
8-K
NOVNQ
NVN Liquidation, Inc.
15 May 23
Novan Reports First Quarter 2023 Financial Results and Provides
6:50am
ARS
2022 FY
NOVNQ
NVN Liquidation, Inc.
27 Apr 23
Annual report to shareholders
9:05am
DEF 14A
NOVNQ
NVN Liquidation, Inc.
Definitive proxy
27 Apr 23
9:00am
8-K
NOVNQ
NVN Liquidation, Inc.
7 Apr 23
Departure of Directors or Certain Officers
5:26pm
S-8
NOVNQ
NVN Liquidation, Inc.
30 Mar 23
Registration of securities for employees
4:31pm
10-K
2022 FY
NOVNQ
NVN Liquidation, Inc.
Annual report
30 Mar 23
6:47am
8-K
NOVNQ
NVN Liquidation, Inc.
30 Mar 23
Novan Reports Full Year 2022 Financial Results and Provides
6:36am
CT ORDER
NOVNQ
NVN Liquidation, Inc.
20 Mar 23
Confidential treatment order
8:30am
8-K
NOVNQ
NVN Liquidation, Inc.
16 Mar 23
Entry into a Material Definitive Agreement
4:21pm
424B3
NOVNQ
NVN Liquidation, Inc.
16 Mar 23
Prospectus supplement
4:20pm
424B5
NOVNQ
NVN Liquidation, Inc.
15 Mar 23
Prospectus supplement for primary offering
4:15pm
8-K
NOVNQ
NVN Liquidation, Inc.
13 Mar 23
Other Events
6:07am
8-K
NOVNQ
NVN Liquidation, Inc.
7 Mar 23
Results of Operations and Financial Condition
8:06am
8-K
NOVNQ
NVN Liquidation, Inc.
6 Jan 23
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
8:05am